Provectus’s Substack
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
When an Old Molecule Outsmarts a New Virus
AI, STING, COVID-19, and Provectus’s proprietary synthetic small molecule's Rose Bengal Sodium’s therapeutic intelligence
Nov 12
•
Provectus Biopharmaceuticals
3
October 2025
Investing by the Golden Rule: How One Patient Is Helping Fund Access to Oral PV-10
Sometimes the most powerful principle in life is quite simple: Do unto others as you would have them do unto you
Oct 2
•
Provectus Biopharmaceuticals
6
September 2025
From Surgery to Immunity: How Provectus’s PV-10 and RB-PDAT Can Reimagine the Scalpel in Oncology and Ophthalmology
What if Keytruda could treat two very different diseases, with similar mechanistic intent, like cancer and dermatology, or Humira for dermatology…
Sep 22
•
Provectus Biopharmaceuticals
4
A Provectus/VisiRose Update
Ophthalmology; Injectable solid tumors: Penile squamous cell carcinoma; Veripure; LinkedIn
Sep 2
•
Provectus Biopharmaceuticals
4
August 2025
50+ Years, a Trillion+ Dollars: What America’s “War on Cancer” Has Gotten Us
America entered the war on cancer in 1971. The goal was bold and rather straightforward: find a cure.
Aug 19
•
Provectus Biopharmaceuticals
Balls in the air; Shots on goal; Looking around corners
In a business context:
Aug 5
•
Provectus Biopharmaceuticals
3
July 2025
Redefining Drug Development: How the FDA’s New Voucher Program Could Accelerate Provectus’s Affordable Cancer Immunotherapy Mission
The Food and Drug Administration (FDA) introduced a new regulatory tool that could reshape the future of drug development.
Jul 24
•
Provectus Biopharmaceuticals
6
When the Treatment Hurts More Than the Disease
In addition to financial toxicity from cancer drugs, it’s time we talk about their life toxicity
Jul 10
•
Provectus Biopharmaceuticals
7
Advancing Across Programs
July 2025 Update
Jul 4
•
Provectus Biopharmaceuticals
5
June 2025
Reassessing Rose Bengal: The 150-Year-Old Textile Dye Reveals Multi-Layered Anti-Cancer Potential as Provectus’s Rose Bengal Sodium Molecule
AI-assisted analysis of ~500 peer-reviewed medical articles from PubMed on “rose bengal” and “cancer”
Jun 26
•
Provectus Biopharmaceuticals
3
Two Golden Rules. One Uncommon Path.
For some, there’s the Golden Rule: “Do unto others as you would have them do unto you.”
Jun 22
•
Provectus Biopharmaceuticals
8
Understanding Rose Bengal Sodium: Biotech Blind Spots and Systems Thinking
For nearly 150 years, rose bengal was seen as a dye. That’s all it’s been allowed to be in the modern pharmaceutical world, until a small biotech began…
Jun 17
•
Provectus Biopharmaceuticals
3
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts